Sign In
Buy MGNX
$4.69
+0.110 (+2.40%)
At Close: Jun 23, 2026
BidaskClub Downgrades MacroGenics (NASDAQ:MGNX) to Sell
08:58am, Saturday, 11'th Apr 2020
MacroGenics (NASDAQ:MGNX) was downgraded by research analysts at BidaskClub from a “hold” rating to a “sell” rating in a research note issued to investors on Thursday, BidAskClub reports. Othe
$7.43 Million in Sales Expected for MacroGenics Inc (NASDAQ:MGNX) This Quarter
08:04am, Saturday, 11'th Apr 2020
Equities research analysts expect MacroGenics Inc (NASDAQ:MGNX) to post sales of $7.43 million for the current fiscal quarter, according to Zacks. Three analysts have made estimates for MacroGenics’
Man Group plc Buys 11,000 Shares of MacroGenics Inc (NASDAQ:MGNX)
11:04am, Thursday, 09'th Apr 2020
Man Group plc grew its stake in shares of MacroGenics Inc (NASDAQ:MGNX) by 7.7% during the fourth quarter, HoldingsChannel reports. The firm owned 153,318 shares of the biopharmaceutical company’s s
Connor Clark & Lunn Investment Management Ltd. Takes Position in MacroGenics Inc (NASDAQ:MGNX)
08:58am, Wednesday, 08'th Apr 2020
Connor Clark & Lunn Investment Management Ltd. acquired a new position in MacroGenics Inc (NASDAQ:MGNX) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fun
Credit Suisse AG Grows Stake in MacroGenics Inc (NASDAQ:MGNX)
09:02am, Tuesday, 07'th Apr 2020
Credit Suisse AG grew its holdings in MacroGenics Inc (NASDAQ:MGNX) by 35.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 43,565 shares of the bi
Edited Transcript of IMAB.OQ earnings conference call or presentation 31-Mar-20 12:00pm GMT
05:43am, Wednesday, 01'st Apr 2020
Full Year 2019 I-Mab Earnings Call
MacroGenics (NASDAQ:MGNX) Upgraded to "Buy" at Zacks Investment Research
10:04am, Thursday, 26'th Mar 2020
MacroGenics (NASDAQ:MGNX) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Thursday, Zacks.com reports. The firm currently has a $6
ImmunoGen: Tremendous Value In Your Turnaround Stock
03:32pm, Wednesday, 25'th Mar 2020
Despite the Corona bear market, ImmunoGen is showing signs of a comeback. In its latest earnings report, the company demonstrated substantial spending reduction
MacroGenics (NASDAQ:MGNX) Stock Rating Lowered by Zacks Investment Research
09:24am, Wednesday, 25'th Mar 2020
MacroGenics (NASDAQ:MGNX) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday, Zacks.com reports. According t
Does MacroGenics, Inc.’s (NASDAQ:MGNX) CEO Pay Compare Well With Peers?
03:43pm, Tuesday, 24'th Mar 2020
Scott Koenig became the CEO of MacroGenics, Inc. (NASDAQ:MGNX) in 2001. This report will, first, examine the CEO...
Jefferies Group LLC Sells 20,232 Shares of MacroGenics Inc (NASDAQ:MGNX)
11:30am, Monday, 23'rd Mar 2020
Jefferies Group LLC reduced its stake in MacroGenics Inc (NASDAQ:MGNX) by 64.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). Th
Citigroup Inc. Sells 13,432 Shares of MacroGenics Inc (NASDAQ:MGNX)
09:42am, Monday, 23'rd Mar 2020
Citigroup Inc. cut its position in shares of MacroGenics Inc (NASDAQ:MGNX) by 27.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission.
Edited Transcript of ZLAB.OQ earnings conference call or presentation 19-Mar-20 12:30pm GMT
09:51pm, Thursday, 19'th Mar 2020
Q4 2019 Zai Lab Ltd Earnings Call
Zai Lab Announces Financial Results for Full Year Ended December 31, 2019 and Corporate Updates
04:21pm, Thursday, 19'th Mar 2020
Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced financial results for the twelve months ended December 31, 2019 and corpor
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
11:37am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commen
